share_log

Earnings Preview For Taro Pharmaceutical Indus

Earnings Preview For Taro Pharmaceutical Indus

太郎製藥行業收益預覽
Benzinga ·  01/25 03:01

Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2024-01-25. Here's what investors need to know before the announcement.

太郎製藥工業公司(紐約證券交易所代碼:TARO)定於2024-01-25星期四發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。

Analysts estimate that Taro Pharmaceutical Indus will report an earnings per share (EPS) of $0.30.

分析師估計,太郎製藥工業公司將公佈每股收益(EPS)0.30美元。

Taro Pharmaceutical Indus bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

太郎製藥工業集團的多頭希望聽到該公司宣佈他們不僅超過了這一預期,而且還希望爲下一季度提供積極的指導或預測的增長。

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

新投資者應注意,有時對股票價格影響最大的不是收益超過或失敗,而是指導方針(或預測)。

Past Earnings Performance

過去的收益表現

Last quarter the company beat EPS by $0.20, which was followed by a 2.3% drop in the share price the next day.

上個季度,該公司每股收益高出0.20美元,隨後第二天股價下跌2.3%。

Here's a look at Taro Pharmaceutical Indus's past performance and the resulting price change:

以下是太郎藥業過去的表現以及由此產生的價格變化:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate 0.18 0.31 0.31 0.87
EPS Actual 0.38 0.40 0.18 0.19
Price Change % -2.3% 0.11% -5.68% -1.26%
季度 2024 年第二季度 2024 年第一季度 2023 年第四季度 2023 年第三季度
每股收益估算 0.18 0.31 0.31 0.87
實際每股收益 0.38 0.40 0.18 0.19
價格變動% -2.3% 0.11% -5.68% -1.26%

eps graph

Stock Performance

股票表現

Shares of Taro Pharmaceutical Indus were trading at $42.07 as of January 23. Over the last 52-week period, shares are up 37.71%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

截至1月23日,太郎製藥工業公司的股票交易價格爲42.07美元。在過去的52週中,股價上漲了37.71%。鑑於這些回報率普遍爲正數,長期股東可能會看漲本業績。

To track all earnings releases for Taro Pharmaceutical Indus visit their earnings calendar on our site.

要追蹤Taro Pharmaceutical Indus發佈的所有業績,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論